Last 24 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q4 '25 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q2 '19 | Q4 '18 | Q2 '18 | Q4 '17 | Q2 '17 | Q4 '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 41.73 | 17.81 | 15.90 | 21.63 | 59.59 | — | — | — | — | — | — | 76.03 | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 12.70 | 5.31 | 4.34 | 9.54 | 8.10 | 7.08 | 7.32 | 10.62 | 16.75 | 45.47 | 168.23 | 8.15 | 224.46 | 80.33 | 51.25 | 26.04 | 113.30 | 32.54 | 30.89 | 4.82 | — |
| — | -25.1% | -40.7% | -10.1% | -51.6% | -84.4% | -95.7% | +30.3% | -92.5% | -43.4% | +228.2% | -68.7% | +98.1% | +146.9% | +65.9% | +440.0% | — | — | — | — | — | |
| P/B Ratio | 7.39 | 7.10 | 7.60 | 5.94 | 7.94 | 5.99 | 5.41 | 7.59 | 7.45 | 6.82 | 7.12 | 5.51 | 8.32 | 5.39 | 5.37 | 7.07 | 5.38 | 6.97 | 4.19 | 2.68 | — |
| — | +18.5% | +40.5% | -21.8% | +6.6% | -12.1% | -24.0% | +37.9% | -10.5% | +26.6% | +32.6% | -22.1% | +54.7% | -22.7% | +28.1% | +163.2% | — | — | — | — | — | |
| P/FCF | 62.49 | 19.95 | 34.20 | 20.91 | 266.61 | — | — | — | — | — | — | — | — | — | — | 6.67 | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 45.58 | 16.27 | 15.09 | 29.64 | 83.61 | — | — | — | — | — | — | 37.42 | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | 46.80 | 16.60 | 19.84 | 29.64 | 89.57 | — | — | — | — | — | — | 38.58 | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q4 '25 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q2 '19 | Q4 '18 | Q2 '18 | Q4 '17 | Q2 '17 | Q4 '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.1% | 90.1% | 89.4% | 88.3% | 50.6% | 47.1% | 24.3% | 180.9% | -24.8% | 412.2% | -1033.2% | 45.1% | -810.5% | -451.7% | -281.5% | -52.6% | -531.4% | -58.0% | 323.5% | -7.2% | -104.6% |
| — | +91.1% | +268.0% | -51.2% | +303.7% | -88.6% | +102.4% | +301.5% | +96.9% | +191.2% | -267.0% | +185.6% | -52.5% | -679.4% | -187.0% | -636.1% | -408.0% | +5.8% | +415.8% | +93.7% | -17.3% | |
| Operating Margin | 25.4% | 30.1% | 26.5% | 21.5% | 8.7% | -15.4% | -28.9% | -40.3% | -109.1% | -356.8% | -1703.1% | 19.1% | -1806.2% | -677.5% | -410.9% | -106.2% | -740.7% | -123.9% | -118.2% | -32.9% | -145.4% |
| — | +295.3% | +191.7% | +153.4% | +108.0% | +95.7% | +98.3% | -311.2% | +94.0% | +47.3% | -314.5% | +118.0% | -143.9% | -447.0% | -247.6% | -223.2% | -409.3% | -17.5% | +13.9% | +82.3% | +10.9% | |
| Net Margin | 31.1% | 29.8% | 32.7% | 25.9% | 64.3% | -3.6% | -20.5% | -22.1% | -81.7% | -373.7% | -1545.0% | 10.7% | -1645.4% | -587.8% | -335.8% | -77.3% | -533.2% | -83.9% | -121.0% | -57.7% | -137.7% |
| — | +925.9% | +259.0% | +217.1% | +178.7% | +99.0% | +98.7% | -306.9% | +95.0% | +36.4% | -360.1% | +113.8% | -208.6% | -600.8% | -177.4% | -34.1% | -287.2% | +30.9% | +30.4% | +64.3% | -8.3% |
| Metric | TTM | Q2 '26 | Q4 '25 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q2 '19 | Q4 '18 | Q2 '18 | Q4 '17 | Q2 '17 | Q4 '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 20.2% | 10.7% | 15.6% | 4.2% | 17.7% | -0.8% | -4.5% | -4.0% | -8.8% | -15.1% | -15.1% | 2.3% | -14.6% | -11.9% | -10.7% | -5.8% | -7.8% | -4.3% | -5.8% | -11.6% | -17.7% |
| — | +1469.4% | +448.6% | +206.3% | +300.7% | +94.9% | +70.4% | -272.9% | +39.5% | -26.5% | -40.9% | +139.8% | -87.7% | -176.0% | -84.8% | +50.0% | +56.1% | +68.1% | +73.1% | -1.0% | -69.6% | |
| ROA | 17.4% | 9.0% | 13.2% | 3.7% | 15.7% | -0.7% | -4.0% | -3.6% | -8.0% | -13.6% | -13.7% | 1.9% | -11.2% | -9.2% | -7.5% | -4.4% | -7.2% | -4.0% | -5.4% | -9.3% | -11.1% |
| — | +1386.7% | +428.1% | +202.8% | +296.6% | +94.9% | +70.6% | -284.0% | +28.5% | -47.9% | -81.5% | +144.2% | -55.0% | -129.7% | -39.7% | +52.8% | +34.6% | +57.1% | +71.0% | +7.6% | -35.9% | |
| ROIC | 19.9% | 14.4% | 16.0% | 3.8% | 2.6% | -4.2% | -8.6% | -8.2% | -14.1% | -21.1% | -26.5% | 7.7% | -44.6% | -24.0% | -13.7% | -9.5% | -15.7% | -9.4% | -8.8% | -17.2% | — |
| — | +441.5% | +286.4% | +146.3% | +118.1% | +80.0% | +67.5% | -205.5% | +68.5% | +12.1% | -92.5% | +181.8% | -184.0% | -155.1% | -55.3% | +45.1% | — | — | +83.0% | +33.9% | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q4 '25 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q2 '19 | Q4 '18 | Q2 '18 | Q4 '17 | Q2 '17 | Q4 '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | — | — | — | — | — |
| — | -29.9% | +133.6% | +80.0% | +60.8% | +144.0% | +7.9% | +47.3% | -23.5% | -23.8% | -27.0% | -57.6% | — | — | — | — | — | — | — | — | — | |
| Debt / EBITDA | 0.08 | 0.05 | 0.10 | 0.15 | 0.31 | — | — | — | — | — | — | 0.08 | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 5.23 | 5.12 | 5.23 | 5.60 | 7.29 | 8.53 | 9.75 | 8.47 | 9.18 | 11.07 | 8.44 | 11.74 | 6.26 | 9.90 | 8.58 | 9.37 | 14.29 | 15.13 | 14.96 | 4.51 | 3.15 |
| — | -40.0% | -46.4% | -33.9% | -20.6% | -22.9% | +15.5% | -27.8% | +46.6% | +11.9% | -1.7% | +25.2% | -56.2% | -34.6% | -42.6% | +107.7% | +353.8% | +459.4% | +192.5% | -21.6% | -53.7% | |
| Quick Ratio | 4.87 | 4.89 | 4.87 | 5.27 | 6.68 | 7.88 | 9.01 | 7.84 | 8.42 | 10.56 | 8.08 | 11.50 | 6.19 | 9.87 | 8.58 | 9.37 | 14.29 | 15.13 | 14.96 | 4.51 | 3.15 |
| — | -38.0% | -46.0% | -32.8% | -20.7% | -25.4% | +11.6% | -31.8% | +36.2% | +7.0% | -5.9% | +22.6% | -56.7% | -34.8% | -42.6% | +107.7% | +353.8% | +459.4% | +192.5% | -21.6% | -53.7% | |
| Interest Coverage | 314.23 | 423.00 | 658.56 | 255.79 | 167.22 | -52.59 | -419.73 | -472.41 | -171.56 | -198.82 | -2014.25 | 127.93 | — | -82.67 | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 24 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ARGX stock.
argenx SE's current P/E is 41.7x. The average P/E over the last 4 quarters is 28.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
argenx SE's current operating margin is 25.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking argenx SE's business trajectory between earnings reports.